Fax: (860) 679-1318;
Should patients consider active surveillance?†
Article first published online: 21 APR 2008
Copyright © 2008 American Cancer Society
Volume 112, Issue 12, pages 2631–2634, 15 June 2008
How to Cite
Albertsen, P. (2008), Should patients consider active surveillance?. Cancer, 112: 2631–2634. doi: 10.1002/cncr.23500
See referenced original article on pages 2664–70, this issue.
- Issue published online: 4 JUN 2008
- Article first published online: 21 APR 2008
- Manuscript Accepted: 25 JAN 2008
- Manuscript Received: 23 JAN 2008
The aging population, the widespread use of prostate-specific antigen testing, and the introduction of new genetic tests will continue to increase the number of incident cases of localized prostate cancer. Because many of these men harbor low-risk disease, clinicians seriously should consider offering an active surveillance protocol.